0001834445-20-000001.txt : 20201203 0001834445-20-000001.hdr.sgml : 20201203 20201203101453 ACCESSION NUMBER: 0001834445-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 EFFECTIVENESS DATE: 20201203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth Clinical Co-Development Fund 2 LP CENTRAL INDEX KEY: 0001834445 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-382087 FILM NUMBER: 201365956 BUSINESS ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 44 0 20 7534 1508 MAIL ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN D 1 primary_doc.xml X0708 D LIVE 0001834445 Abingworth Clinical Co-Development Fund 2 LP 38 JERMYN STREET LONDON X0 UNITED KINGDOM SW1Y 6DN 44 0 20 7534 1508 UNITED KINGDOM None None Limited Partnership true 2020 - Abingworth Clinical Co-Development Fund 2 GP LP 50 LOTHIAN ROAD FESTIVAL SQUARE EDINBURGH X0 UNITED KINGDOM EH3 9WJ Promoter General Partner of the Issuer - Abingworth LLP 38 JERMYN STREET LONDON X0 UNITED KINGDOM SW1Y 6DN Promoter Manager of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false 2020-11-19 true true false 0 Asante Capital Group Advisors LLC 155178 None None 10 East 53rd St. 12th Floor New York NY NEW YORK 10022 All States false Indefinite 207480000 Indefinite false 22 0 true 0 true 0 true The General Partner, or an affiliate of the General Partner, will be entitled to receive management fees and performance-based compensation from the Issuer under the Issuer's governing documents. false Abingworth Clinical Co-Development Fund 2 LP /s/ John Heard John Heard Director of a Member of GP of GP of the Issuer 2020-12-03